Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (41-50 of 548) with videos related to

Pageof 55
Sort By:
Journal of Neural Transmission. Supplementum|January 1, 1986
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's diseaseP Jenner, C D Marsden
Lancet (London, England)|October 27, 1979
Tardive dyskinesiasP Jenner, C D Marsden
Annals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W Olanow
Pharmacology & Therapeutics|February 7, 2006
What has been learnt from study of dopamine receptors in Parkinson's disease?M J Hurley, P Jenner
Neurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W Olanow
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugsP Jenner, C D Marsden
Research Communications in Chemical Pathology and Pharmacology|November 1, 1973
Comparative in vitro hepatic metabolism of some tertiary N-methyl tobacco alkaloids in various speciesP Jenner, J W Gorrod
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1988
In vitro inhibition by stiripentol of rat brain cytochrome P-450-mediated naphthalene hydroxylationM Mesnil, B Testa, P Jenner
FEBS Letters|March 25, 1998
Sulphite enhances peroxynitrite-dependent alpha1-antiproteinase inactivation. A mechanism of lung injury by sulphur dioxide?M Reist, P Jenner, B Halliwell
Biochemical Pharmacology|October 1, 1988
Ex vivo inhibition of rat brain cytochrome P-450 activity by stiripentolM Mesnil, B Testa, P Jenner
Pageof 55

Showing results (41-50 of 548) with videos related to

Sort By:
Pageof 55
Journal of Neural Transmission. Supplementum|January 1, 1986
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's diseaseP Jenner, C D Marsden
Lancet (London, England)|October 27, 1979
Tardive dyskinesiasP Jenner, C D Marsden
Annals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W Olanow
Pharmacology & Therapeutics|February 7, 2006
What has been learnt from study of dopamine receptors in Parkinson's disease?M J Hurley, P Jenner
Neurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W Olanow
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugsP Jenner, C D Marsden
Research Communications in Chemical Pathology and Pharmacology|November 1, 1973
Comparative in vitro hepatic metabolism of some tertiary N-methyl tobacco alkaloids in various speciesP Jenner, J W Gorrod
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1988
In vitro inhibition by stiripentol of rat brain cytochrome P-450-mediated naphthalene hydroxylationM Mesnil, B Testa, P Jenner
FEBS Letters|March 25, 1998
Sulphite enhances peroxynitrite-dependent alpha1-antiproteinase inactivation. A mechanism of lung injury by sulphur dioxide?M Reist, P Jenner, B Halliwell
Biochemical Pharmacology|October 1, 1988
Ex vivo inhibition of rat brain cytochrome P-450 activity by stiripentolM Mesnil, B Testa, P Jenner
Pageof 55